Skip to content

A Clinical Trial To Find Out How Effective Suvarna shalaka Agnikarma Is In Vatakantaka.

A Randomised Controlled Clinical Trial To Study The Effect Of Suvarna shalaka Agnikarma In Vatakantaka With Special Reference To Plantar Fasciitis - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072167
Enrollment
70
Registered
2024-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M722- Plantar fascial fibromatosis

Interventions

None listed

Sponsors

Dr Pranjali Sanjay Narwade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Diagnose patients with classical features of VATAKANTAKA i.e. – Ruk , vedana 2)Patients of age group 40-60 years irrespective of religion and caste.

Exclusion criteria

Exclusion criteria: 1)Patients with known case of uncontrolled diabetes, hypertension, cardiac disease, CA, TB 2)Local skin disease at agnikarma site. 3)Calcaneal stress fracture. 4)Anarha’s of agnikarma mentioned of classics.

Design outcomes

Primary

MeasureTime frame
Reduction in Sign and Symptoms of Vatkantaka after Agnikarma With SuvarnashalakaTimepoint: 10 days

Secondary

MeasureTime frame
Where the trial group stands in comparison with control group.Timepoint: 18 months

Countries

India

Contacts

Public ContactDr Pranjali Sanjay Narwade

SMBT Ayurved College And Hospital Dhamangaon Igatpuri Nashik

adkpc74@gmail.com9689339928

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026